Show simple item record

dc.contributor.authorFitzsimons, CP
dc.contributor.authorvan Bodegraven, E
dc.contributor.authorSchouten, M
dc.contributor.authorLardenoije, R
dc.contributor.authorKompotis, K
dc.contributor.authorKenis, G
dc.contributor.authorvan den Hurk, M
dc.contributor.authorBoks, MP
dc.contributor.authorBiojone, C
dc.contributor.authorJoca, S
dc.contributor.authorSteinbusch, HW
dc.contributor.authorLunnon, Katie
dc.contributor.authorMastroeni, DF
dc.contributor.authorMill, J
dc.contributor.authorLucassen, PJ
dc.contributor.authorColeman, PD
dc.contributor.authorvan den Hove, DL
dc.contributor.authorRutten, BP
dc.date.accessioned2016-02-11T10:00:13Z
dc.date.issued2014-06-25
dc.description.abstractExperimental evidence has demonstrated that several aspects of adult neural stem cells (NSCs), including their quiescence, proliferation, fate specification and differentiation, are regulated by epigenetic mechanisms. These control the expression of specific sets of genes, often including those encoding for small non-coding RNAs, indicating a complex interplay between various epigenetic factors and cellular functions.Previous studies had indicated that in addition to the neuropathology in Alzheimer's disease (AD), plasticity-related changes are observed in brain areas with ongoing neurogenesis, like the hippocampus and subventricular zone. Given the role of stem cells e.g. in hippocampal functions like cognition, and given their potential for brain repair, we here review the epigenetic mechanisms relevant for NSCs and AD etiology. Understanding the molecular mechanisms involved in the epigenetic regulation of adult NSCs will advance our knowledge on the role of adult neurogenesis in degeneration and possibly regeneration in the AD brain.en_GB
dc.description.sponsorshipInternationale Stichting Alzheimer Onderzoek (ISAO)en_GB
dc.description.sponsorshipNetherlands Organization for Scientific Research (NWO)en_GB
dc.description.sponsorshipMaastricht University Medical Centre +en_GB
dc.identifier.citationVol. 9, pp. 25 -en_GB
dc.identifier.doi10.1186/1750-1326-9-25
dc.identifier.grantnumber07551en_GB
dc.identifier.grantnumber11532en_GB
dc.identifier.grantnumber09552en_GB
dc.identifier.grantnumber13515en_GB
dc.identifier.grantnumber916.11.086en_GB
dc.identifier.grantnumberH64.09.016en_GB
dc.identifier.urihttp://hdl.handle.net/10871/19698
dc.language.isoenen_GB
dc.publisherBioMed Centralen_GB
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pubmed/24964731en_GB
dc.relation.urlhttp://molecularneurodegeneration.biomedcentral.com/articles/10.1186/1750-1326-9-25en_GB
dc.rightsCopyright © Fitzsimons et al.; licensee BioMed Central Ltd. 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​4.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.en_GB
dc.subjectAdult Stem Cellsen_GB
dc.subjectAgingen_GB
dc.subjectAlzheimer Diseaseen_GB
dc.subjectAnimalsen_GB
dc.subjectEpigenesis, Geneticen_GB
dc.subjectHumansen_GB
dc.subjectNeural Stem Cellsen_GB
dc.subjectNeurogenesisen_GB
dc.titleEpigenetic regulation of adult neural stem cells: implications for Alzheimer's disease.en_GB
dc.typeArticleen_GB
dc.date.available2016-02-11T10:00:13Z
dc.identifier.issn1750-1326
exeter.place-of-publicationEngland
dc.descriptionPublished onlineen_GB
dc.descriptionJournal Articleen_GB
dc.descriptionResearch Support, Non-U.S. Gov'ten_GB
dc.descriptionReviewen_GB
dc.identifier.eissn1750-1326
dc.identifier.journalMolecular Neurodegenerationen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record